Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Nature Immunology
|
February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitope
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology
|
September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitope
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Cell
|
May 6, 2017
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Davide F Robbiani, Leonia Bozzacco, Jennifer R Keeffe, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature Immunology
|
October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Science (New York, N.Y.)
|
May 7, 2026
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design
Ashwin N Skelly, Harry B Gristick, Hui Li, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design
Ashwin N Skelly, Harry B Gristick, Hui Li, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Nature Immunology
|
February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitope
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology
|
September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitope
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Cell
|
May 6, 2017
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Davide F Robbiani, Leonia Bozzacco, Jennifer R Keeffe, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature Immunology
|
October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Science (New York, N.Y.)
|
May 7, 2026
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design
Ashwin N Skelly, Harry B Gristick, Hui Li, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design
Ashwin N Skelly, Harry B Gristick, Hui Li, et al.
Page
of 4